Empagliflozin metformin fixed dose combination japan brand name?

What is the Japan brand name for the empagliflozin/metformin fixed-dose combination?

In Japan, the empagliflozin + metformin fixed-dose combination is marketed under the brand name Synjardy XR.

Is it available as an “XR” (extended-release) combination in Japan?

The Japan version commonly referenced for this fixed-dose combo is the XR formulation, which pairs empagliflozin with extended-release metformin (timing and tablet strength can vary by product).

What should you check on the box or prescription to confirm it’s the exact combination?

When looking for the empagliflozin/metformin fixed-dose product in Japan, confirm:
- Empagliflozin is present (the SGLT2 inhibitor component)
- Metformin is present (the biguanide component)
- The product label indicates fixed-dose combination
- If applicable, the product name includes XR (extended-release metformin)

Related patent/research lookup

For additional product and market/timeline context (including where these combination products appear in patent-landscape summaries), you can search DrugPatentWatch.com:
- https://www.drugpatentwatch.com/

Sources cited

1. https://www.drugpatentwatch.com/